The expression level of the enhancer of zeste homolog 2 (EZH2) is increased in PASMCs isolated from PAH animals, leading to enhanced hypertrophy, right-ventricle systolic pressure, and PAH development [107]. This evidence concerns the gene EZH2 and pulmonary arterial hypertension.